What the day of your PRP knee injection is like

On the day, PRP is typically delivered as an outpatient injection for knee pain or early osteoarthritis, using a concentration of the patient’s own platelets to support endogenous repair rather than acting as an instant painkiller. The appointment is designed to be “in and out” on the same day, without an operating‑theatre pathway, and the injection may be placed under imaging guidance into the knee joint or, in some cases, nearby soft tissues depending on the diagnosis.

A common one‑visit pathway at a consultant‑led clinic includes: confirming the treatment plan and consent, taking a blood sample, processing it to concentrate platelets, then performing the injection. Local anaesthetic is often used to numb the skin and needle track; once this wears off, it is common to notice an ache, stiffness, or a “heavy/full” feeling in the knee. Temporary soreness and swelling can occur early on as part of the expected response.

For the rest of the day and the day after, clinics commonly advise a protected, low‑demand routine rather than “pushing through” symptoms:

• Relative rest, with the leg elevated when possible.
• Short, indoor walking for essentials, rather than long walks or exercise sessions.
• Avoiding strenuous, impact, or twisting activity on the treated knee in the early period.

Policies on driving, work, and same‑day travel are usually agreed individually (for example, depending on whether the right or left knee was treated and whether any sedative medication was used). This practical overview is deliberately presented without in‑text reference codes, keeping the focus on what typically happens in clinic and during the first 1–2 days.

How your knee usually feels in the first week

The first week can feel counter‑intuitive: discomfort is not unusual because PRP is intended to trigger a local, short‑lived inflammatory response as part of the healing process. Rather than repeating day‑0 precautions, this section focuses on how the sensations often evolve through the first week.

In the first few days, many people notice the knee feels more “angry” than baseline, particularly once any local anaesthetic has fully worn off. In clinic recovery guides, this early period is framed as a time to protect the joint: symptoms may fluctuate from morning to evening, and a short pain flare can be part of the expected response. A retrospective study of 225 PRP‑treated knees in knee osteoarthritis also reported that post‑injection pain was more pronounced in some situations (for example, where PRP preparation involved higher‑dose anticoagulant, or where hyperuricaemia was poorly controlled), which underlines that early soreness varies between individuals and can be influenced by both patient factors and how PRP is prepared [1].

As the week progresses, the initial inflammation often starts to settle for many people, even if the knee is still stiff after sitting or first thing in the morning. Many protocols keep activity deliberately simple in this week‑1 window: relative rest, avoiding impact or heavy loading, and sticking to gentle, controlled movement (often guided by a physiotherapist or a clinic plan) rather than squats, running, twisting sports or heavy gym work.

Pain relief plans vary, but some clinicians advise avoiding anti‑inflammatory medicines such as ibuprofen, naproxen or aspirin after PRP, because they may blunt the intended inflammatory healing response. Some protocols instead suggest comfort measures such as intermittent icing and using other analgesics such as paracetamol if appropriate for the person’s medical history. Where there is anticoagulant medication use, a history of gout/high uric acid, kidney disease, or stomach ulcer risk, pain‑relief choices are typically individualised by the treating clinician.

Not everything in week 1 is “normal”. Urgent clinical contact (the injecting clinic, NHS 111, or emergency services) is generally appropriate if any of the following develop over a few hours to a day:

• rapidly worsening pain that is out of proportion to day‑to‑day fluctuation (especially if weight‑bearing becomes suddenly difficult)
• marked or spreading redness, a hot swollen knee that is getting worse rather than easing, or any wound leakage
• fever or feeling systemically unwell (for example, new shivering or nausea)
• new calf swelling, calf tenderness, or sudden breathlessness (which requires urgent assessment)

At MSK Doctors, early rehabilitation expectations are usually agreed in advance and can be adjusted during follow‑up if the first‑week flare is more intense than expected.

What usually happens from week 2 to week 4

In the weeks after the first week, many people notice the knee becomes less reactive day‑to‑day, even though “good days and bad days” are still common—especially after a change in walking distance, standing time, or gym/physio load.

A practical marker of progress in this period is often less knee “reactivity” after ordinary activity: for example, a short flat walk or a trip to the shops is more likely to feel manageable during the activity and not trigger as much soreness later the same day. By around a month, some people find stairs, standing from a chair, or walking on uneven ground feels a little easier; others feel similar to pre‑injection, which can still be within the range of expected response at that point. A small clinical study in 39 people with knee osteoarthritis reassessed outcomes at 1 month and found that many improved by then, but response varied, and biological factors (such as VEGF levels in the PRP) were associated with differences in short‑term improvement—so early lack of change does not necessarily predict the later result [2].

Activity in this phase is commonly progressed in small steps rather than big jumps. In week‑by‑week clinic guidance, this often means gradually increasing gentle, controlled movement and introducing more structured rehabilitation (for example, prescribed physiotherapy or a home programme), while keeping day‑to‑day demands realistic. Desk‑based work and light household tasks are often feasible during this period (sometimes with pacing and breaks), whereas heavier manual roles may still be limited by prolonged kneeling, carrying, or repeated stairs.

One common mistake that can create an apparent “step back” is treating a single good day as a green light for impact or pivoting activity—such as running, jumping, twisting sports, or a long hike—before the knee has settled into a more stable pattern. Many clinic protocols still restrict heavy, high‑impact, or rotational loads in the early weeks to avoid stressing tissues while they are adapting, even when walking is starting to feel easier.

When you might feel improvement and how long it can last

From about the one‑month point onwards, symptom change tends to be easier to judge: the knee is usually past the early flare stage, and improvements in pain and function—if they occur—are often more noticeable over subsequent weeks. This is often gradual rather than dramatic, with progress showing up as longer walks, easier stairs, or less post‑activity soreness over the course of weeks rather than days.

The best “backbone” evidence for when PRP starts to help in knee osteoarthritis comes from randomised trials that follow people for months, not days. A 2025 meta‑analysis pooling 18 RCTs (1,995 patients) reported that intra‑articular PRP performed better than placebo for both pain and function at 1, 3, 6, and 12 months [3]. In practical terms, this supports a typical timeline where measurable benefit can begin to show over the first few months, with many patients reaching their best results around 3–6 months, and improvements remaining clinically relevant out to 12 months in a substantial proportion of patients [3].

Variation is real, and it cuts both ways. In a 39‑patient cohort reassessed at 1 month after a single PRP injection, many improved by that time, but the response rate and size of change differed between individuals and was associated with growth‑factor content (including VEGF levels) in the PRP sample [2]. The RCT meta‑analysis also highlights that outcomes are influenced by PRP characteristics (including platelet concentration), which helps explain why two people treated “with PRP” can have different timelines and results [3].

Even when PRP works well, it is not a cure for osteoarthritis: the underlying joint wear and metabolic drivers do not automatically stop, and a minority of patients do not report a meaningful change. PRP’s delayed curve also fits with the way it is thought to work biologically—by modulating joint inflammation over time rather than acting as an immediate anaesthetic—an idea supported by preclinical work showing changes in inflammatory signalling after PRP in a knee osteoarthritis model [4].

Putting PRP in context can help set expectations against other injections used for knee OA. A systematic review comparing PRP with corticosteroid injections found both approaches generally safe and effective, with some studies suggesting steroids may give faster short‑term relief, while PRP tends to build more slowly but can be more sustained over subsequent months [5]. That difference in “speed versus durability” is often the reason PRP does not produce a same‑week “wow” effect, even in people who go on to do well by month 3 or month 6.

What you can and cannot do after PRP

Planning day‑to‑day life after PRP usually works best by thinking in phases (early days, the first few weeks, and the following months), because most protocols deliberately protect the knee early on and then build activity gradually.

Early days to first week: protect the knee (relative rest)

The first week is often treated as an “inflammation and soreness” period in which the aim is to settle the knee and avoid provoking it. Many protocols therefore focus on simple, gentle movement only (often brief, comfortable walks and prescribed range‑of‑motion work), while avoiding intense exercise. In practical UK terms, this is the phase where long dog walks, a gym session, kneeling for DIY, or a full day on the feet (for example a standing shift in retail or care) is often scaled back.

Driving soon after PRP is usually treated as a safety decision rather than a “PRP rule”: it often depends on which knee was injected, whether swelling or pain limits braking, and whether the person can comfortably control the pedals. Where driving is needed for work (for example commuting across Lincolnshire), it is typically cleared with the treating clinician, and practicalities such as insurer or employer requirements are also considered.

The next few weeks: gradual build‑up (controlled movement)

As the knee settles, activity is usually progressed in small, planned steps rather than big jumps. Clinic guidance commonly encourages increasing gentle, controlled movement under supervision (for example physiotherapy or a home programme), while still avoiding high‑impact or strenuous loads that can irritate the knee. Typical examples in this window can include steadily increasing flat walking distances, carefully re‑introducing everyday tasks such as light gardening, and (where symptoms allow) low‑load options like a static bike.

Return to work often differs by job demands. Desk‑based roles are commonly easier to restart once walking and sitting tolerance are improving (sometimes with pacing breaks and a manageable commute), whereas heavier manual work—farming tasks, repeated lifting/carrying, prolonged kneeling, or lots of stairs—may still be restricted if it reliably flares symptoms.

Later (often over subsequent months): reintroducing higher loads in stages

Over subsequent months, activity is often built towards more demanding strengthening and more normal day‑to‑day function, provided the knee is tolerating the programme. Many protocols still reintroduce higher‑impact or pivoting activities cautiously and in sequence—progressive strengthening first, then options such as swimming or outdoor cycling, and only later a graded return to running and twisting sports (for example football), if appropriate and cleared by the clinical team.

Across all phases, many clinic protocols aim to avoid “spikes” in load (a sudden long hike, an intense gym session, or a first game of golf after weeks off), because higher‑impact or twisting demands can trigger a pain flare and may disrupt early tissue adaptation. Mild, short‑lived aches after a planned increase can occur during rehab; sharp, escalating, or persistent pain after a specific activity is often treated as a cue to step back and discuss the plan with the treating clinician or physiotherapist.

Managing pain flares and follow‑up with MSK Doctors

A short‑lived pain flare after PRP is a recognised part of the early response in some knees, particularly in the first days and couple of weeks. In a retrospective study of 225 PRP‑treated knees, higher post‑injection pain was common enough to analyse, and it was more likely when PRP preparation involved higher‑dose anticoagulant or when hyperuricaemia was poorly controlled [1]. Preclinical work also supports the idea that PRP’s effects are linked to gradual immune signalling shifts (for example changes in macrophage behaviour and inflammatory cytokines), rather than an immediate “numbing” effect [4].

When symptoms spike after a rehab step‑up (for example, a longer walk in week 2), conservative measures are often used to settle things while keeping the programme on track:

• Pacing load for 24–72 hours and temporarily stepping down exercises to the last tolerated level.
• Intermittent icing for comfort.
• Using pain relief that has been agreed with the treating consultant or GP; some clinicians advise avoiding NSAIDs such as ibuprofen, naproxen, and aspirin after PRP unless a clinician specifically advises otherwise.

Certain patterns are less “expected flare” and usually justify prompt medical review after any joint injection. Examples include a hot, increasingly red knee with fever in the first few days after injection; rapidly worsening swelling with inability to weight‑bear; wound leakage; or new calf swelling and breathlessness (which needs urgent assessment for clotting complications). A severe, escalating flare in a knee with known gout or uncontrolled hyperuricaemia also matters, given the association between poor urate control and higher post‑PRP pain reported in the 225‑knee series [1].

Because flare intensity can be influenced by medical factors and preparation variables, the pre‑injection assessment matters: anticoagulant or antiplatelet medicines, a history of gout/hyperuricaemia, and broader metabolic health are typically reviewed alongside imaging and examination findings. In the retrospective study, both anticoagulant dosing in preparation and hyperuricaemia tracked with higher inflammatory markers in joint fluid, which helps explain why two people can have very different early‑pain experiences after an otherwise similar injection [1].

Follow‑up is usually structured around function as well as pain—often with a planned review point and access to advice if symptoms change unexpectedly. Evidence also remains imperfect: most strong trial data relate to intra‑articular PRP for knee osteoarthritis, protocols vary, and individual response cannot be predicted, even though meta‑analysis data suggest PRP can improve pain and function versus placebo at 1, 3, 6 and 12 months in trial populations [3].

1. [1] Inadequate anticoagulation and hyperuricemia cause knee pain after platelet-rich plasma injection: A retrospective study. (2024). https://doi.org/10.1177/10225536241277604 https://doi.org/10.1177/10225536241277604
2. [2] Impact of Vascular Endothelial Growth Factor Concentration on the Short-term Efficacy of Platelet-Rich Plasma (PRP) Therapy for Knee Osteoarthritis. (2025). https://doi.org/10.1177/19476035251352178 https://doi.org/10.1177/19476035251352178
3. [3] PRP Injections for the Treatment of Knee Osteoarthritis: The Improvement Is Clinically Significant and Influenced by Platelet Concentration: A Meta-analysis of Randomized Controlled Trials. (2025). https://doi.org/10.1177/03635465241246524 https://doi.org/10.1177/03635465241246524
4. [4] Efficacy and Safety of Intra-articular Platelet-Rich Plasma (PRP) Versus Corticosteroid Injections in the Treatment of Knee Osteoarthritis: A Systematic Review of Randomized Clinical Trials. (2025). https://doi.org/10.7759/cureus.80948 https://doi.org/10.7759/cureus.80948